Bridge to Life Raises $110 Million in Series C Funding
Bridge to Life, a company based in Northbrook, Illinois, specializing in organ transplant technology, has raised $110 million in a Series C funding round. The financing was led by Soleus Capital, with participation from Lauxera Capital Partners.
Company Background
Bridge to Life focuses on improving the preservation and transportation of organs for transplantation. By developing advanced solutions, the company aims to increase the success rates of organ transplants and expand the viability of donor organs.
Leadership Perspective
Steve Schweighardt, Chairman and Founder, along with CEO Don Webber, are at the helm of the company. The leadership team is committed to leveraging this new capital to further their mission in the organ transplant sector.
Use of Funds
While specific plans for the $110 million have not been detailed, the funding is expected to support the company's ongoing research and development efforts. This may include enhancing their existing technology and expanding their market reach.
Investors
The Series C round was spearheaded by Soleus Capital, a notable investor in the healthcare sector. Lauxera Capital Partners also participated in this significant funding effort.
This investment marks a pivotal step for Bridge to Life as it seeks to advance its organ transplant solutions and potentially impact the lives of many awaiting transplants.